Call your doctor before leaving home if you think you’ve been exposed to COVID-19 or have symptoms

Due to the presence of COVID-19 in our community, visitor restrictions are in place for all Duke clinics and hospitals. For your safety and the safety of others, we recommend patients do not bring a visitor to Duke clinics, if at all possible. If a visitor must accompany a patient, only one individual over 12 years of age is allowed. Patients and visitors will be screened for symptoms upon arrival. Individuals with flu-like symptoms are not allowed. View the complete list of Visitor Restrictions.

Effective immediately, Duke Health is prioritizing and rescheduling some non-emergent or non-critical surgeries, procedures, and appointments. Check our COVID-19 (Coronavirus) page for updates.

Melanoma Biorepository - Clinical Trial

What is the Purpose of this Study?

We are doing this study to look at blood, tumor, and lymph node tissue from people with melanoma so we can improve diagnosis and therapies for people with melanoma.
What is the Condition Being Studied?
Melanoma

Who Can Participate in the Study?

- Adults with melanoma having surgery, biopsy, or treatment

Age Group
Adults

What is Involved?

If you choose to join this study, you will:
- Have a biopsy of your melanoma taken
- Have a tissue sample of your lymph node(s) taken
- Have a blood sample taken up to 3 times a month

Study Details

Full Title
Melanoma Biorepository
Principal Investigator
Surgical Oncologist
Protocol Number
IRB: PRO00100644
Phase
Phase N/A
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698